Focus

Pfizer BioNTech

No Clinical Data in Health Canada’s ‘Thorough’ Review of Latest Pfizer COVID Shot

Health Canada says the safety and effectiveness of Pfizer’s XBB.1.5 shot is inferred from studies conducted on its previous mRNA products.

Dec 14, 2023

Dec 14

70 Percent of Deaths from Pfizer Vaccine in Japan Reported Within 10 Days of Jab: Study

Number of deaths within the first 10 days of vaccination was ’significantly higher' than those between 11 and 180 days among people aged 64 and under.

Pfizer BioNTech

No Clinical Data in Health Canada’s ‘Thorough’ Review of Latest Pfizer COVID Shot

70 Percent of Deaths from Pfizer Vaccine in Japan Reported Within 10 Days of Jab: Study

Health Canada Authorizes Updated Pfizer-BioNTech COVID Vaccine

Study: COVID-19 Vaccine Caused Rare ‘White Dot Syndrome’

‘Statistically Significant Increase’ in Myopericarditis and Single-Organ Cutaneous Vasculitis Found After COVID-19 Vaccination

Forensic Analysis of Deaths in Pfizer’s Early mRNA Vaccine Trial Found Significant Inconsistencies

Pfizer, J&J Pressured South Africa Into Shielding Companies From COVID Vaccine Injury Claims: Documents

Flu Vaccines and COVID Booster Shots Brought Forward Due to New Variant

Pfizer Documents Show COVID-19 Vaccines Contain Potentially Harmful ‘Modified’ RNA, not mRNA

Israeli Government Mysteriously Loses Pfizer Vaccine Agreement That Promised to Share Population’s Data

Recipe for Disaster: Combining COVID-19 BA4/5 and Influenza mRNA

Pfizer Plans to Hike Price of US COVID-19 Vaccine by 400 Percent

Health Canada Approves Pfizer Vaccine for Children 6 Months and Older

Pfizer Seeks US Authorization of COVID-19 Boosters for Latest Omicron Variants

11-Year-Old Girl Returns Home after Myocarditis Scare Following Her Second COVID-19 Vaccine

Second Pfizer Jab Taken After Shorter Interval May Have Higher Myocarditis, Pericarditis Risk, Doctor Says

North Carolina Physicians Demand End to Hospital’s COVID-19 Vaccine Trial on Children

Pfizer, BioNTech Ask FDA to Authorize COVID-19 Vaccine Booster for Children Aged 5–11

Moderna President: We ‘Strongly Recommend’ 4th Vaccine Dose For Certain Groups

Call for Investigation Into Increase in Deaths in Young Males in UK